Aurobindo Pharma Vice-Chairman and Managing Director K Nithyananda Reddy said the company’s second quarter performance was subdued, mainly due to macro-environment factors and higher competitive intensity for some products in the US.
Wendy’s draws buyout bid as beef costs and burger rivalry weigh on business
Wendy’s shares jump after Nelson Peltz’s Trian Fund Management offers $7.35 per share to take the burger chain private, as the company faces high beef